Singapore markets close in 2 hours 18 minutes
Straits Times Index
3,289.90 -2.79 (-0.08%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,188.05 +425.02 (+2.39%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,507.92 -2,206.41 (-3.69%) CMC Crypto 200
1,259.32 -11.42 (-0.90%)
GSK plc (GSK.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 05:24PM BST
Loading interactive chart…
- Simply Wall St.
GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
GSK ( LON:GSK ) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q 2023). Net income...
- Benzinga
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding COVID. Vaccines’ sales increased 16% at constant currency to 2.28 billion Pounds, reflecting U.S. demand for Arexvy and strong market growth for Shingrix in International and European markets. Shingrix sales reached 945 million Pounds, up 18% at constant currency, with Arexvy sales of 182 million Pounds. Specialty Medicine sales increased 17% to 2.5 billion poun
- PA Media: Money
GSK raises profit guidance as vaccine demand grows
Emma Walmsley, chief executive officer of the pharmaceutical firm hailed a ‘strong start to 2024’.
© 2024 Yahoo. All rights reserved.